Seminars in Cancer Biology

Papers
(The H4-Index of Seminars in Cancer Biology is 81. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
Editorial Board450
Multifaceted role of chemokines in solid tumors: From biology to therapy447
Advances in biology and novel treatments of SCLC338
The molecular chaperone TRAP1 in cancer: From the basics of biology to pharmacological targeting272
Biology of cancer; from cellular and molecular mechanisms to developmental processes and adaptation243
Updated review on green tea polyphenol epigallocatechin-3-gallate as a cancer epigenetic regulator238
Unveiling the role of PIK3R1 in cancer: A comprehensive review of regulatory signaling and therapeutic implications225
Emerging applications of bacteria as antitumor agents221
Targeting Hippo signaling pathway by phytochemicals in cancer therapy220
Small secretory proteins of immune cells can modulate gynecological cancers216
Carbonic anhydrase IX: A tumor acidification switch in heterogeneity and chemokine regulation215
Deregulated transcription factors in the emerging cancer hallmarks193
Editorial Board187
Critical DNA damaging pathways in tumorigenesis187
Editorial Board183
Origins and molecular effects of hypoxia in cancer183
The IL-1 family in tumorigenesis and antitumor immunity181
Immune cellular components and signaling pathways in the tumor microenvironment179
PIWI-interacting RNAs in human cancer177
Erratum to “RNA regulatory mechanisms controlling TGF-β signaling and EMT in cancer” [Semin. Cancer Biol. 102–103 (2024) 4–16]176
Targeting micro-environmental pathways by PROTACs as a therapeutic strategy176
Gut microbes in gastrointestinal cancers161
Excess body weight and postmenopausal breast cancer: Emerging molecular mechanisms and perspectives157
Association of Chlamydia and Mycoplasma infections with susceptibility to ovarian cancer: A systematic review and meta-analysis152
Innovative trial design in precision oncology147
Thinking small to win big? A critical review on the potential application of extracellular vesicles for biomarker discovery and new therapeutic approaches in pancreatic cancer144
Genome chaos: Creating new genomic information essential for cancer macroevolution143
Extracellular vesicles associated microRNAs: Their biology and clinical significance as biomarkers in gastrointestinal cancers142
Enhancing head and neck tumor management with artificial intelligence: Integration and perspectives141
The impact of obesity and lipids on cancer: Insights into mechanisms and potential interventions140
Molecular targets of tyrosine kinase inhibitors in thyroid cancer135
Multifaceted functions of chronic inflammation in regulating tumor dormancy and relapse130
Special issue: Deregulated transcription factors in the cancer therapeutic challenges: An update on cancer stemness features126
Targeting monocarboxylate transporters (MCTs) in cancer: How close are we to the clinics?120
Microbiome dysbiosis and epigenetic modulations in lung cancer: From pathogenesis to therapy118
Multi-omic markers of intraductal papillary mucinous neoplasms progression into pancreatic cancer117
Anticancer properties of chimeric HDAC and kinase inhibitors117
Therapy-induced modulation of extracellular vesicles in hepatocellular carcinoma116
Extracellular vesicles in glioblastoma: Biomarkers and therapeutic tools115
Atrial fibrillation in cancer patients: Epidemiology, identification and management115
Reprogramming of glycolysis by chemical carcinogens during tumor development114
Cellular stress responses and metabolic reprogramming in cancer progression and dormancy112
Regulation of the aryl hydrocarbon receptor in cancer and cancer stem cells of gynecological malignancies: An update on signaling pathways112
The role of deiodinases on metabolic alteration in cancer111
Metabolic landscape and rewiring in normal hematopoiesis, leukemia and aging111
Anticancer natural products targeting immune checkpoint protein network110
Editorial Board108
Targeting the “undruggable”: RNA-binding proteins in the spotlight in cancer therapy107
How far have we explored fungi to fight cancer?106
Regulation of epithelial-mesenchymal transition by tumor microenvironmental signals and its implication in cancer therapeutics106
Advancement of cancer immunotherapy using nanoparticles-based nanomedicine106
Cancer cell heterogeneity & plasticity in glioblastoma and brain tumors105
Curcumin and colorectal cancer: An update and current perspective on this natural medicine103
New biological and immunological approaches to cancer therapy: Basic and clinical aspects101
The intricacies of NRF2 regulation in cancer101
Vibrational spectroscopy for decoding cancer microbiota interactions: Current evidence and future perspective98
Insight into the role of multiple signaling pathways in regulating cancer stem cells of gynecologic cancers98
Unravelling the complexities of resistance mechanism in pancreatic cancer: Insights from in vitro and ex-vivo model systems98
Role of LDH in tumor glycolysis: Regulation of LDHA by small molecules for cancer therapeutics97
Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer97
Modulation of the tumor microenvironment by natural agents: implications for cancer prevention and therapy96
Editorial Board95
The foundational framework of tumors: Gametogenesis, p53, and cancer95
Editorial Board95
Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders91
Cytotoxic activity of l-lysine alpha-oxidase against leukemia cells90
Emerging perspectives on growth factor metabolic relationships in the ovarian cancer ascites environment90
Microbiota and lung cancer88
The role of RNA processing and regulation in metastatic dormancy88
Mechanisms and applications of apolipoproteins and apolipoprotein mimetic peptides: Common pathways in cardiovascular disease and cancer87
The microbiome-immune cell interaction network: Advancing tumor immunotherapy86
Transcription networks rewire gene repertoire to coordinate cellular reprograming in prostate cancer86
Leveraging epigenetic alterations in pancreatic ductal adenocarcinoma for clinical applications85
Metabolic reprogramming of tumor microenviroment by engineered bacteria85
Functionalized-DNA nanostructures as potential targeted drug delivery systems for cancer therapy84
Chaperonins in cancer: Expression, function, and migration in extracellular vesicles84
BubR1 and SIRT2: Insights into aneuploidy, aging, and cancer83
Drivers of centrosome abnormalities: Senescence progression and tumor immune escape82
Plant lectins and their usage in preparing targeted nanovaccines for cancer immunotherapy81
Analytical demands to use whole-genome sequencing in precision oncology81
Emerging roles of long noncoding RNAs in chemoresistance of pancreatic cancer81
Artificial intelligence and pathology: From principles to practice and future applications in histomorphology and molecular profiling81
0.37358999252319